Article
Transforming growth factor-beta 1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein.
The Journal of biological chemistry - 28 Feb 2003
Janssens Katrien, ten Dijke Peter, Ralston Stuart H, Bergmann Carsten, Van Hul Wim
Abstract excerpt
Transforming growth factor-beta1 (TGF-beta1) is secreted as a latent precursor, consisting of a homodimer of the latency-associated peptide and the mature peptide. TGFbeta-1 can only exert its many functions after going from this latent to an active state, in which the binding site of the mature peptide for its receptor is no longer shielded by the latency-associated peptide. We and others reported that mutations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
